A61K9/1629 - CPC Classification Index

ClassID:

20084 ⎘

A61K9/1629 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients Organic macromolecular compounds

Sub-classes:

A61K9/1635 » {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates} 1,8K
A61K9/1641 » {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers} 1,1K
A61K9/1652 » {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin } 3,2K
A61K9/1658 » {Proteins, e.g. albumin, gelatin} 507

Recent Application in this class:

20260090985

2026-04-02

ORAL MUCOSAL FORMULATIONS OF ASPIRIN

20250360166

2025-11-27

Cisplatin particles and uses thereof

20250120917

2025-04-17

COMPOSITION FOR FORMULATION, FORMULATION AND METHOD FOR MANUFACTURING COMPOSITION FOR FORMULATION

20250090664

2025-03-20

PIEZOELECTRIC SHEAR-THINNING MATERIAL COMPOSITIONS AND METHODS FOR USE

20250057855

2025-02-20

PHARMACEUTICAL COMPOSITIONS OF MIFEPRISTONE

20240238307

2024-07-18

SUSTAINED RELEASE OLANZAPINE FORMULATIONS

20240216424

2024-07-04

CISPLATIN PARTICLES AND USES THEREOF

20240216382

2024-07-04

PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

20240173251

2024-05-30

BIO-ERODIBLE OCULAR IMPLANTS FOR TREATMENT OF CONDITIONS OF THE EYE

#10

20240122944

2024-04-18

Pharmaceutical compositions of mifepristone

#11

20240016742

2024-01-18

MICROSPHERE PRODUCING SYSTEM AND MICROSPHERE PRODUCING METHOD

#12

20230364063

2023-11-16

ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME

#13

20230088240

2023-03-23

ACCELERATING THE DRYING RATE OF SOFTGEL CAPSULES

#14

20230085008

2023-03-16

Pharmaceutical compositions of mifepristone

#15

20220339159

2022-10-27

PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

#16

20220323458

2022-10-13

SUSTAINED RELEASE OLANZAPINE FORMULATIONS

#17

20220257518

2022-08-18

LONG-LASTING FORMULATION CONTAINING RIVASTIGMINE, AND METHOD FOR PREPARING SAME

#18

20220218902

2022-07-14

DEVICE AND METHOD FOR IMPROVING RETENTION OF A THERAPY IN THE BLADDER

#19

20220186372

2022-06-16

Particle coating methods and apparatus

#20

20220054452

2022-02-24

Duloxetine sprinkles

#21

20210386869

2021-12-16

DELIVERY OF CYCLIC COMPOUND BY USING CARRIER

#22

20210379013

2021-12-09

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

#23

20210239440

2021-08-05

Biocompatible Ammunition

#24

20210196888

2021-07-01

Device and method for improving retention of a therapy in the bladder

#25

20210106560

2021-04-15

Duloxetine sprinkles

#26

20210085607

2021-03-25

CONTINUOUS MICROPARTICLE MANUFACTURE

#27

20200276122

2020-09-03

Hydrogel toxin-absorbing or binding nanoparticles

#28

20200188352

2020-06-18

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

#29

20200179286

2020-06-11

CARRIER STRUCTURE AND DRUG CARRIER, AND PREPARING METHODS THEREOF

#30

20200109928

2020-04-09

Biocompatible ammunition

#31

20200078334

2020-03-12

Duloxetine sprinkles

#32

20200054702

2020-02-20

Methodology and Formulation for Creating a Powder of an Encapsulated Cannabis-Based Component Embedded in a Polymer Matrix

#33

20200024736

2020-01-23

Particle coating methods and apparatus

#34

20190350897

2019-11-21

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

#35

20190142746

2019-05-16

Hydrogel toxin-absorbing or binding nanoparticles

#36

20180360844

2018-12-20

Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability

#37

20180263957

2018-09-20

DULOXETINE SPRINKLES

#38

20180256809

2018-09-13

Positionable delivery device and method

#39

20180161306

2018-06-14

Duloxetine sprinkles

#40

20180085318

2018-03-29

Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds

#41

20180072748

2018-03-15

Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same

#42

20180042888

2018-02-15

Monensin water dispersible granules by wet granulation

#43

20170202843

2017-07-20

Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof

#44

20170196854

2017-07-13

USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS

#45

20170114191

2017-04-27

Method for producing polymer latex particle coated with silver nanoparticles

#46

20170079909

2017-03-23

Hydrogel toxin-absorbing or binding nanoparticles

#47

20170066774

2017-03-09

Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same

#48

20170042987

2017-02-16

Nanospheres encapsulating bioactive material and method for formulation of nanospheres

#49

20170035940

2017-02-09

Foam carrier for bone grafting

#50

20160331889

2016-11-17

Positionable delivery device and method

#51

20160317505

2016-11-03

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

#52

20160310417

2016-10-27

Formulations and Methods For Targeted Ocular Delivery of Therapeutic Agents

#53

20150190518

2015-07-09

Pharmaceutical compositions providing enhanced drug concentrations

#54

20150064264

2015-03-05

Pharmaceutical dosage forms comprising a low-solubility drug and a polymer

#55

20150010626

2015-01-08

Escalating dosing regimen for effecting weight loss and treating obesity

#56

20140377365

2014-12-25

SUSTAINED-RELEASE FORMULATION OF ROTIGOTINE

#57

20140356439

2014-12-04

Lipidated glycoprotein particles and methods of use

#58

20140322325

2014-10-30

Pharmaceutical compositions providing enhanced drug concentrations

#59

20140187572

2014-07-03

Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C

#60

20140093577

2014-04-03

Compositions and methods of making sustained release liquid formulations

#61

20140004200

2014-01-02

POLYMER COMPOSITIONS WITH BIOACTIVE AGENT, MEDICAL ARTICLES, AND METHODS

#62

20130231485

2013-09-05

Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same

#63

20130129817

2013-05-23

Method of treating malignant solid tumors

#64

20130017156

2013-01-17

Cefdinir and cefixime formulations and uses thereof

#65

20120259022

2012-10-11

Pharmaceutical compositions providing enhanced drug concentrations

#66

20120135969

2012-05-31

NOVEL POWDERED CRYSTALLINE MEDICINES FOR INHALATION

#67

20120009248

2012-01-12

Preservation of bioactive materials by spray drying

#68

20110311620

2011-12-22

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

#69

20110294902

2011-12-01

Pharmaceutical compositions providing enhanced drug concentrations

#70

20110059171

2011-03-10

ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES

#71

20110033551

2011-02-10

Nucleic acid microspheres, production and delivery thereof

#72

20100329982

2010-12-30

PARTICLES WITH INDUCIBLE CHANGE OF SHAPE

#73

20100137447

2010-06-03

METHOD FOR THE PRODUCTION OF ADSORBATES OF A RASAGILINE SALT HAVING A WATER-SOLUBLE ADJUVANT

#74

20100068152

2010-03-18

Ex vivo modifiable particle or polymeric based final dosage form

#75

20100048511

2010-02-25

COMPLEX FORMULATION FOR PREVENTING OR TREATING OSTEOPOROSIS WHICH COMPRISES SOLID DISPERSION OF VITAMIN D OR ITS DERIVATIVE AND BISPHOSPHONATE

#76

20100028420

2010-02-04

CONTROLLED RELEASE COMPOSITION AND PROCESS

#77

20100021518

2010-01-28

Foam carrier for bone grafting

#78

20090304789

2009-12-10

NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS

#79

20090304785

2009-12-10

Escalating dosing regimen for effecting weight loss and treating obesity

#80

20090142404

2009-06-04

PHARMACEUTICAL DOSAGE FORMS COMPRISING A LOW-SOLUBILITY DRUG AND A POLYMER

#81

20090022801

2009-01-22

Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms

#82

20090022656

2009-01-22

Lipidated glycoprotein particles and methods of use

#83

20080145440

2008-06-19

Microparticle preparation and medical composition

#84

20080132532

2008-06-05

Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C

#85

20080131514

2008-06-05

Preservation of bioactive materials by spray drying

#86

20080038358

2008-02-14

Dry powder formulations of antihistamine for nasal administration

#87

20070259334

2007-11-08

Preservation of bioactive materials by spray drying

#88

20070191230

2007-08-16

Emulsifier system and pesticidal formulations containing the emulsifier system

#89

20070026082

2007-02-01

Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form

#90